baber/WOPTO huggingface dataset:
Patent AU-2011265293-A1 (AU)
Title: Combination therapy with lisdexamphetamine and extended release guanfacine
Inventor: ERMER JAMES C
IPC: A61K9/22
Filed: 2011-06-10
Abstract: The present invention relates to treating children and adults with suboptimal responses to Attention Deficit Hyperactivity Disorder (ADHD) monotherapy. More specifically, the present invention relates to a method for treating ADHD in a patient which comprises administering to the patient an extended release guanfacine composition adjunctively with a lisdexamphetamine composition.
Patent AU-2011289283-A1 (AU)
Title: Chimeric promoters and methods of use
Inventor: TAO YUMIN
IPC: C12N15/29
Filed: 2011-08-12
Abstract: Compositions and methods comprising promoters from the 4- hydroxyphenylpyruvate dioxygenase (HPPD) gene and active variants and fragments thereof, as well as chimeric promoters employing regulatory regions of the HPPD promoters are provided. Further provided are expression cassettes and plants comprising the various promoters disclosed herein operably linked to a polynucleotide of interest. Methods employing the various promoters described herein to modulate the expression of polynucleotides of interest are further provided.
Patent AU-2011295938-A1 (AU)
Title: Lipids suitable for liposomal delivery of protein-coding RNA
Inventor: GEALL ANDREW
IPC: A61K39/12
Filed: 2011-08-31
Abstract: RNA is encapsulated within a liposome for in vivo delivery. The RNA encodes a polypeptide of interest, such as an immunogen for immunisation purposes. The liposome includes at least one compound selected from the group consisting of compounds of formula (I) and formula (XI).
Patent AU-2011305680-A1 (AU)
Title: Fusion cage with combined biological delivery system
Inventor: KLEINER JEFFREY
IPC: A61B17/58
Filed: 2011-09-20
Abstract: The present invention relates to an apparatus and method for near-simultaneous and integrated delivery of bone graft material during the placement of surgical cages or other medical implants in a patient's spine. The integrated fusion cage and graft delivery device according to various embodiments delivers and disperses biologic material through a fusion cage to a disc space and, without withdrawal from the surgical site, may selectably detach the fusion cage for deposit to the same disc space. The integrated fusion cage and graft delivery device is formed such that a hollow tube and plunger selectively and controllably place bone graft material and a fusion cage in or adjacent to the bone graft receiving area.
Patent AU-2011314307-A1 (AU)
Title: Location based transactions
Inventor: TANAKA RAY HIDEKI
IPC: G06Q30/00
Filed: 2011-09-13
Abstract: A user's location is determined by location information communicated by a user device, such as a smart phone. Merchants near the user location are determined and selected. Merchant payment information is transmitted to the user device so that the user can easily make a payment to the merchant through the user device. Merchant offerings may also be sent to the user device for purchase and subsequent payment, where the merchant offerings may be specifically selected for the user.
Patent AU-2011324414-A1 (AU)
Title: Trans-2-decenoic acid derivative and pharmaceutical agent containing the same
Inventor: IINUMA MUNEKAZU
IPC: A61P25/02
Filed: 2011-11-01
Abstract: The purpose of the present invention is to provide a novel trans-2-decenoic acid derivative and a pharmaceutically acceptable salt thereof, and a medicament containing the compound described above as an active component and having a neurotrophic factor-like effect and a side effect reducing effect due to administration of anti-cancer agent which are highly safe. A trans-2-decenoic acid derivative or the pharmaceutically acceptable salt thereof, which is a compound of the present invention, is specifically represented by general formula (1) (where Y represents -O-, -NR-, or -S-, R represents a hydrogen atom, an alkyl group, a dialkylamino group, or the like, and W represents a substituent such as a dialkylaminoalkyl group), and is extremely highly useful as a preventive or therapeutic agent for dementia, Alzheimer's disease, Parkinson's disease, depression and the like, a therapeutic or repairing agent for spinal cord injury, or a medicament such as an agent for reducing the side effect due to administration of anti-cancer agent.
Patent AU-2011328649-A1 (AU)
Title: Treatment device
Inventor: EMEKCI BULENT
IPC: A46B15/00
Filed: 2011-10-28
Abstract: The invention relates to a treatment device, in particular for treating the oral cavity and pharynx and/or the teeth, comprising a treatment head, which can be removably fastened to a handpiece and which has a head piece having a plurality of bristles and which has an electromechanical transducer (19) in the head piece for producing a mechanical oscillation or wave to be transferred to a treatment area.
Patent AU-2011356346-A1 (AU)
Title: Face mask and method of its production
Inventor: SAROCH JAN
IPC: A41D13/11
Filed: 2011-02-23
Abstract: The invention relates to a face mask for removal of biological and mechanical impurities from breathed and/or exhaled air, comprising an inner textile layer and an outer textile layer, between which there is arranged a filtering layer of polymer nanofibres and/or active layer of polymer nanofibres, which in its structure contains a biocidal substance(s). The outer as well as the inner textile layer are formed of microfibres, while at least the outer textile layer and with it neighbouring filtering or active layer of polymer nanofibres are hydrophobic, and all layers are interconnected by a net of joints, that prevent their mutual motion and reduce permeability of the face mask only minimally. The inner textile layer is on periphery of the face mask provided with a layer of an adhesive for fastening 'to the face of the user. This method of fixing the face mask to the face secures' perfect adhesion of the face mask to the skin along its entire periphery, thus preventing breathing of an unfiltered air. The invention further relates to a method for production of such face mask.
Patent AU-2011357694-A1 (AU)
Title: Apparatus and methods for tracking the location of fracturing fluid in a subterranean formation
Inventor: QU QI
IPC: E21B43/26
Filed: 2011-10-25
Abstract: In some embodiments, a method of determining the location of fracturing fluid in a subterranean formation includes providing purpose-designed additives (PDA) in the fracturing fluid. As the fracturing fluid moves through a fracture in the formation, the PDA solidifies and forms a barrier in the path of the fracturing fluid. In response to a pressure increase in the well contacting the barrier, at least one signal is generated and detected to provide information about the fracturing fluid and/or fracture.
Patent AU-2011371755-A1 (AU)
Title: Apoptosis-inducing agent
Inventor: NIITSU YOSHIRO
IPC: A61P43/00
Filed: 2011-06-21
Abstract: This invention relates to: a novel use of GST-π and GST-π suppressing agents; an apoptosis-inducing agent containing as active components a drug that suppresses GST-π and a drug that suppresses autophagy; a medical composition containing said agent; and a method using said medical composition for treating diseases associated with abnormal apoptosis.
Patent WO-2012145789-A1 (WO)
Inventor: BANKS PATRICK EDWARD
IPC: G16H20/13
Filed: 2012-04-26
Abstract: A method of packing medication for a subject, the medication being packed into packaging including a number of receptacles for receiving medication, the method including, in a packing station, determining packing data indicative of medication to be packed for the subject, providing an indication of a medication to be packed and, providing an indication of a receptacle into which the medication should be packed, thereby allowing a user to pack the medication into the receptacle in the packaging.
Patent WO-2013026087-A1 (WO)
Title: Apparatus and method for making an object
Inventor: ELSEY JUSTIN
IPC: B29C67/00
Filed: 2012-08-17
Abstract: A method for making an object and an apparatus (100) for making the object in accordance with the method is disclosed. A section (124) of the object is formed by irradiating a layer of material (104) with a radiation (116), the layer of material being disposed on a material receiving surface (102) of a flexible element (101) shaped by a shaping member (110) contacting the flexible element (102). The radiation (116) passes through the member (110) and the flexible element (101). The member (110) is tilted to induce a peeling separation of the member (110) from the element (101).
Patent AU-2012213951-A1 (AU)
Title: A closed container comprising an activated factor VII polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit
Inventor: ARENTSEN ANNE CHARLOTTE
IPC: A61K9/00
Filed: 2012-08-14
Abstract: The present invention relates to a closed container holding a composition of an activated Factor VII polypeptide in an amount of in the range of 2.5-90 mg per imL volume of the container. The invention also relates to various processes for the preparation of such closed containers, a kit including such containers and a method of using the kit.
Patent AU-2012216513-A1 (AU)
Title: Systems and methods to identify intentionally placed products
Inventor: HARKNESS DAVID H
IPC: H04N7/16
Filed: 2012-08-29
Abstract: - 45 SYSTEMS AND METHODS TO IDENTIFY INTENTIONALLY PLACED PRODUCTS Systems and methods to identify intentionally placed products in media content are disclosed. Specifically, an audience measurement monitor is configured to detect an intentionally placed product appearing in media presented by an information presenting device. The audience measurement monitor has a detector (32, 132) to detect a presence of the intentionally placed product in the media and to detect an interaction with the intentionally placed product, the interaction including a selection of the intentionally placed product by an audience member, a program identifier (36,136) to identify the media in which the intentionally placed product is located, and a data logging device (34,134) to log at least one of the intentionally placed product detected by the detector, the interaction with the intentionally placed product detected by the detector, and the identity of the media. 6645973_1 P012789D1speci
Patent AU-2012217509-A1 (AU)
Title: Bike braking device having alarm
Inventor: SU WEICHUNG
IPC: B62J6/00
Filed: 2012-01-30
Abstract: Disclosed is a bike braking device (10) having an alarm, which comprises a brake block (20), an alarm (22) arranged at the brake block (20), an electricity supply element (24) electrically connected to the alarm (22), and two conductors (26) arranged within the brake block(20), wherein the conductors (26) are electrically connected to the alarm (22) and the electricity supply element (24) with one end of them being exposed at the surface of the brake block (20), so that, when the brake block (20) is controlled by a brake block calliper (30) and forces the conductors (26) to touch a wheel rim (32) or a braking plate (62) with the exposed ends thereof, an internal circuit of the brake block (20) is activated,so that the alarm (22) can produce an alarm signal to achieve the effect of an alarm.
Patent AU-2012226241-A1 (AU)
Title: Method and implant for replacing damaged meniscal tissue
Inventor: GEDET PHILIPPE
IPC: A61F2/38
Filed: 2012-02-16
Abstract: A method and apparatus for replacing damaged meniscal tissue includes a meniscus implant including a porous body having a plurality of interconnected open micro-pores and one or more open cavities for receiving meniscal tissue. The interconnected micro-pores are arranged to allow fluid to flow into the porous body and are in fluid communication with the one or more open cavities.
Patent AU-2012229859-A1 (AU)
Title: Nitrogen-containing saturated heterocyclic compound
Inventor: IIJIMA TORU
IPC: C07D403/12
Filed: 2012-03-15
Abstract: The present invention provides a nitrogen-containing saturated heterocyclic compound that is useful as a renin inhibitor/antagonist. A compound represented by formula [I] or a pharmaceutically acceptable salt thereof. (In the formula, R
Patent AU-2012234690-A1 (AU)
Title: Photobioreactors and culture bags for use therewith
Inventor: BOILY SABIN
IPC: C12M1/42
Filed: 2012-04-02
Abstract: There is provided a culture bag for use in a photobioreactor. The bag can comprise at least one wall having at least one inlet disposed at a first end portion of the at least one wall or adjacently thereto. The at least one wall defines an internal chamber for receiving a culture medium. The bag also comprises at least one injector for injecting a gas inside the bag, the at least one injector being disposed at a second end portion of the at least one wall or adjacently thereto. The bag also comprises at least one outlet for harvesting a content of the bag, the at least one outlet being disposed at the second end portion of the at least one wall or adjacently thereto. The bag can be translucent or transparent and be effective for holding and sealingly maintaining the culture medium inside the bag and inside the photobioreactor. There is also provided a photobioreactor and a photobioreator modular system.
Patent AU-2012243650-A1 (AU)
Title: Washer
Inventor: IM MYONG HUN
IPC: D06F33/46
Filed: 2012-01-16
Abstract: A washer of the present invention comprises: a casing; a tub, which is arranged inside the casing, for accommodating water; a drum, which is rotatably provided inside the tub, for accommodating laundry; a gasket, which is interposed between the casing and the tub, for preventing the water inside the tub from leaking in between the tub and the casing; gasket nozzles, which are provided on the gasket, for circulating and spraying into the drum water that is accommodated in the drum; eddy-nozzles, which are provided on the gasket, for converting the water into eddies and spraying same into the drum; and a turbo wash button for setting or releasing a turbo wash for spraying water through the gasket nozzles when the drum is rotating or for spraying water through the eddy-nozzles when the drum is rotating.
Patent AU-2012247071-A1 (AU)
Title: Compressor digital control failure shutdown algorithm
Inventor: DOTZENROD RYAN J
IPC: F04C18/02
Filed: 2012-11-09
Abstract: A method of controlling the loading and unloading of a compressor includes selectively loading and unloading a compressor by engaging and disengaging, respectively, compressor members with the controller in response to system load data, monitoring at least one of the discharge pressure and the suction pressure at a predetermined time interval for a continuous time period, storing values based on the at least one of the discharge pressure and the suction pressure during the continuous time period, and determining a predetermined value indicative of compressor operation in which the compressor members are engaged. The method further includes comparing at least one of the stored values with the predetermined value and providing a signal to cease operation of the compressor when the comparison fails to indicate compressor operation in which the compressor members are engaged. 248 \-SENSOR COTO E-0 4 108 ? 16 17 18 212- 204 208 ------- --- F-G . 12
Patent AU-2012269684-A1 (AU)
Title: Rabies virus like particle production in plants
Inventor: D AOUST MARC-ANDRE
IPC: C12N15/47
Filed: 2012-06-13
Abstract: A method of producing a virus like particle (VLP) in a plant is provided. The method comprises introducing a first nucleic acid into the plant, or portion of the plant. The first nucleic acid comprising a first regulatory region active in the plant operatively linked to a nucleotide sequence encoding a native rabies virus structural protein. The nucleotide sequence may further comprise one or more than one amplification element. Optionally, a second nucleic acid might be introduced into the plant, or portion of the plant. The second nucleic acid comprising a second regulatory region active in the plant and operatively linked to a nucleotide sequence encoding a matrix protein, for example but not limited to a rabies matrix protein. The plant or portion of the plant is incubated under conditions that permit the expression of the nucleic acids, thereby producing the VLP.
Patent AU-2012272731-A1 (AU)
Title: Compositions and methods for treatment of chronic fatigue
Inventor: KAISER JON D
IPC: A61P25/28
Filed: 2012-06-22
Abstract: Pharmaceutical compositions and methods for the treatment of chronic fatigue in human patients comprising a central nervous system (CNS) stimulant in a daily low-dosage amount in combination with therapeutically effective daily amounts of micronutrients, comprising acetyl L- carnitine, L-tyrosine, N-acetyl cysteine, and alpha-lipoic acid. The CNS and micronutrient components may be in an oral dosage composition containing a low dosage amount of CNS stimulant such as about 2.5 mg methylphenidate HCl together with about 60 - 250 mg acetyl L- carnitine, 50 - 200 mg L-tyrosine, 60 - 250 mg N-acetyl cysteine, and 25 - 100 mg alpha-lipoic acid.
Patent AU-2012287626-A1 (AU)
Title: Method for transmitting an uplink reference signal in a multi-node system and terminal using same
Inventor: KANG JI WON
IPC: H04W4/70
Filed: 2012-07-27
Abstract: The present invention relates to a method for transmitting an uplink reference signal in a multi-node system and a terminal using same. The method comprises the steps of: receiving a synchronization signal from a node; receiving parameters for a virtual cell identifier(ID) from the node; generating an uplink demodulation reference signal(DM-RS) using the parameters for the virtual cell ID; and transmitting the generated uplink DM-RS to the node, wherein a physical cell ID is a cell ID obtained from the synchronization signal, and the parameters for the virtual cell ID are parameters used for generating the uplink DM-RS in the replacement of the physical cell ID.
Patent AU-2012302723-A1 (AU)
Title: Pyrazole compound and use thereof for medical purposes
Inventor: MIURA TOMOYA
IPC: C07D403/12
Filed: 2012-08-30
Abstract: A compound represented by general formula [Ib] or a pharmaceutically acceptable salt thereof. [In the formula, each symbol is as defined in the description.]
Patent AU-2012317099-A1 (AU)
Title: Leadless free-cutting copper alloy and method for producing the same
Inventor: LEE BEUM JAE
IPC: C22F1/08
Filed: 2012-07-31
Abstract: Disclosed is a leadless free-cutting copper alloy that exhibits superior machinability, cold workability and dezincification resistance and a method for producing the same. The leadless free-cutting copper alloy comprises 56 to 77% by weight of copper (Cu), 0.1 to 3.0% by weight of manganese (Mn), 1.5 to 3.5% by weight of silicon (Si), and the balance of zinc (Zn) and other inevitable impurities, thus exhibiting superior eco-friendliness, machinability, cold workability and dezincification resistance.
Patent AU-2012323829-A1 (AU)
Title: Heart imaging method
Inventor: FOURAS ANDREAS
IPC: G06T19/00
Filed: 2012-10-10
Abstract: The present invention relates to imaging of a human or animal heart, particularly imaging of movement of the heart and can be used for imaging function and form in a wide range of research, medical, veterinary and industrial applications. In particular, the present invention provides a method and apparatus for imaging a subject heart, the method including the steps of (1) recording at least one in vivo image of a lung of the subject in one or more regions; (2) applying said at least one in vivo image to a 2D or 3D heart model; and (3) reconstructing a 2D or 3D image field of the subject heart.
Patent AU-2012336586-A1 (AU)
Title: Electronic device having audio output unit
Inventor: SHIN YUN-SUNG
IPC: H04M1/02
Filed: 2012-10-31
Abstract: An electronic device having an audio output unit with case design that provides a wide resonance space for enhanced sound quality and improved shock resistance. The electronic device includes a housing, a first space longitudinally penetrating a side region of the housing, and a second space connected to the first space and configured to accommodate an audio output unit therein.
Patent AU-2012337336-A1 (AU)
Title: Eluting medical devices
Inventor: CAMPBELL CAREY V
IPC: A61M29/02
Filed: 2012-09-05
Abstract: The invention is directed to eluting medical devices that enable consistent "on-demand" delivery of therapeutic agents to a vessel. The medical device of the current invention comprises an expandable member, a hydrophilic coating comprising at least one therapeutic agent about the expandable member or structural layer and an outer sheath with a variably permeable microstructure. The design and methods disclosed herein ensures that therapeutic agent delivery occurs essentially only during expansion of the expandable member, minimizing coating and/or therapeutic agent loss to the bloodstream and providing controlled delivery to the treatment site.
Patent AU-2012352149-A1 (AU)
Title: Autoimmune disorder treatment using RXR agonists
Inventor: CHANDRARATNA ROSHANTHA A
IPC: A61P37/00
Filed: 2012-12-13
Abstract: The present specification provides RXR agonist compounds, compositions comprising such RXR agonists, and methods using such compounds and compositions to treat an autoimmune disorder, inflammation associated with an autoimmune disorder and/or a transplant rejection as well as use of such RXR agonists to manufacture a medicament and use of such compounds and compositions to treat an autoimmune disorder, inflammation associated with an autoimmune disorder and/or a transplant rejection.
Patent AU-2012352879-A1 (AU)
Title: Devices and methods for shape-based particle separation
Inventor: DI CARLO DINO
IPC: C12Q1/02
Filed: 2012-09-27
Abstract: A particle sorting system includes an inlet and an inertial focusing microchannel disposed in a substrate and having a downstream expanding region at a distal end, wherein the inlet is connected to an upstream end of the microchannel. A source of different shaped particles is connected to the inlet, wherein the source of different shaped particles are configured for continuous introduction into the inlet. A plurality of outlets is connected to the microchannel at the downstream expanding region. Fluidic resistors are located in the respective outlets. Different resistances may be used in the outlets to capture enriched fractions of particles having particular particle shape(s).
Patent AU-2012364924-A1 (AU)
Title: BAP1 mutational analysis in determining susceptibility to, prognosis of, and treatment of melanocytic neoplasia
Inventor: WIESNER THOMAS
IPC: G01N33/48
Filed: 2012-02-16
Abstract: Methods and compositions for diagnosing and prognosmg neoplasms, particularly malignant melanomas, and for identifying patients at high risk for melanocytic nevi and/or melanomas or other cancers are provided. Methods for distinguishing between nevi at high and low risk for malignant transformation and for characterizing or classifying lesions or nevi are also disclosed. Assays and kits for prognosis of melanoma in a human subject comprising assessment of BAP1 protein and/or BAP1 nucleic acid are provided.